January 4, 2017
Gilead reinforces oncology department from Novartis
Gilead Sciences has strengthened its lines with newly appointed Hematology and Oncology Therapeutic Area Head, who came from Novartis.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
January 3, 2017
Shire enters new year with new non-executive director
Shire has entered a new year with a new non-executive director, as it has appointed Ian Clark to the board. His new duties started immediately.
December 30, 2016
7 ways to get heartburn relief
If you have problems with settling your stomach after having a nice meal, even if it had passed a couple of hours, you don’t want to jump to drugs immediately. Try these seven steps to reduce your abdominal pain.
December 30, 2016
Mylan launches three different tablets in US in two days
Mylan has had a rather busy week, as it got approvals for three of its generic medicines in last three days. It announced launching three generics into the multi-billion U.S. worth market on Wednesday and Thursday.
December 30, 2016
Corporate makeovers drive corporate takeovers in 2016 M&A bonanza
In 2016, mega deals became ever more transformative.
German drug and crop chemical maker Bayer AG announced its $66 billion takeover of U.S. agrochemicals company Monsanto Co, while ChemChina signed a $43 billion acquisition of Swiss seeds group Syngenta AG, as consolidation in the sector intensified.
December 30, 2016
Eurofins buys another research company in Spain
Analytical company Eurofins Scientific has broadened its testing facilities in Spain, as it is about to buy a Spanish pharmaceutical company Villapharma Research SL.
December 29, 2016
argenx publishes data from acute myeloid leukemia drug study
Argenx (argenx) is currently working on a therapy for the treatment of acute myeloid leukemia (AML), and during the holiday season, the company has revealed how it is going.
December 28, 2016
Sanofi sues Novo Nordisk over diabetes drug in the U.S.
France’s Sanofi has filed a lawsuit in the United States accusing Novo Nordisk of falsely claiming that Sanofi insulin drugs would no longer be available for many U.S. patients so it could promote its competing drug.
December 27, 2016
Seattle Genetics’ cancer drug put on clinical hold after four deaths
Seattle Genetics Inc said four people had died in trials testing its experimental cancer drug, prompting the U.S. Food and Drug Administration to impose a clinical hold on several early-stage studies.
December 27, 2016
Shire’s Adynovate cleared for young children haemaphilia patients
Shire will now be able to use its Adynovate for treating heamophilia A in children younger than 12 years of age, as the the U.S. Food and Drug Administration (FDA) has approved it for that age group. The FDA has also…